Clinical Imaging
Volume 34, Issue 1 , Pages 47-52 , January 2010

Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification

  • Chan Wha Lee

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang-si, Gyeonggi-do 410-769, South Korea
    • Department of Medicine, Yonsei University Graduate School, Seoul 120-752, South Korea
    • ,
  • Joo-Hyuk Lee

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang-si, Gyeonggi-do 410-769, South Korea
    • Corresponding Author InformationCorresponding author. 111 Jungbalsan-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-769, South Korea. Tel.: +82 31 920 2636; fax: +82 31 920 2643.
    • ,
  • Dae Hong Kim

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang-si, Gyeonggi-do 410-769, South Korea
    • ,
  • Hye Sook Min

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang-si, Gyeonggi-do 410-769, South Korea
    • ,
  • Byung-Kiu Park

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang-si, Gyeonggi-do 410-769, South Korea
    • ,
  • Hwan Sung Cho

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang-si, Gyeonggi-do 410-769, South Korea
    • ,
  • Hyun Guy Kang

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang-si, Gyeonggi-do 410-769, South Korea
    • ,
  • Jin-Suck Suh

      Affiliations

    • Department of Medicine, Yonsei University Graduate School, Seoul 120-752, South Korea
    • ,
  • Shigeru Ehara

      Affiliations

    • Department of Radiology, School of Medicine, Iwate Medical University, Morioka 020-8505, Japan

Received 20 January 2009 ,Accepted 10 March 2009.

References 

  1. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed. 1992;5:303–324
  2. Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat. 2001;68:45–54
  3. Yeung DK, Yang WT, Tse GM. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastasis. Radiology. 2002;225:190–197
  4. Stadlbauer A, Gruber S, Nimsky C, Fahlbusch R, Hammen T, Buslei R, et al. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology. 2006;238:958–969
  5. Oya N, Aoki J, Shinozaki T, Watanabe H, Takagishi K, Endo K. Preliminary study of proton magnetic resonance spectroscopy in bone and soft tissue tumors: an assigned signal at 2.0–2.1 ppm may be a possible indicator of malignant neuroectodermal tumor. Radiat Med. 2000;18:193–198
  6. Wang CK, Li CW, Hsieh TJ, Chien SH, Liu GC, Tsai KB. Characterization of bone and soft tissue tumors with in vivo 1H MR spectroscopy: initial results. Radiology. 2004;232:599–605
  7. Fayad LM, Bluemke DA, McCarthy EF, Weber KL, Barker PB, Jacobs MA. Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging. 2006;23:23–28
  8. Fayad LM, et al. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. AJR Am J Roentgenol. 2007;188:1513–2000
  9. In:  Edelman RR,  Hesselink J,  Zlatkin M, et al. editor. 3rd ed.. Clinical Magnetic Resonance Imaging. vol. 1:Philadelphia: Saunders; 2006;p. 477–481
  10. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30:672–679
  11. Miller BL. A review of chemical issues in 1-H NMR spectroscopy: n-acetyl-l-aspartate, creatinine and choline. NMR Biomed. 1991;4:47–52
  12. Ruiz-Cabello J, Cohen JS. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 1992;5:226–233
  13. Rand SD, Prost R, Haughton V, et al. Accuracy of single voxel proton MR spectroscopy in distinguishing neoplastic from nonneoplastic brain lesions. AJNR Am J Neuroradiol. 1997;18:1695–1704
  14. Krouwer HG, Kim TA, Rand SD, et al. Single voxel proton MR spectroscopy of nonneoplastic brain lesion suggestive of neoplasm. AJNR Am J Neuroradiol. 1998;19:1695–1703
  15. Maheshwari SR, Mukherji SK, Neelon B, et al. The choline/creatinine ratio in five benign neoplasms. Comparison with squamous cell carcinoma by use of in vivo MR spectroscopy. AJNR Am J Neuroradiol. 2000;21:1930–1935
  16. Bitch A, Bruhn H, Vougiouka V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton spectroscopy. AJNR Am J Neuroradiol. 1999;20:1619–1627
  17. Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology. 2002;44:656–666
  18. Vuori K, Kankaanranta L, Hakkinen AM, et al. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology. 2004;230:703–708
  19. Leach MO, Verrill M, Glaholm J, et al. Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment. NMR Biomed. 1998;11:314–340
  20. Baik HM, Sy MY, Yu H, et al. Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T. MAGMA. 2006;19:96–104

☆ This work was supported in part by grants from the National Cancer Center, Korea (0710665-2).

PII: S0899-7071(09)00090-4

doi: 10.1016/j.clinimag.2009.03.013

Clinical Imaging
Volume 34, Issue 1 , Pages 47-52 , January 2010

Article Tools

* Image Usage & Resolution